India's antitrust review of Sun Pharma, Ranbaxy deal may take longer than usual
The Competition Commission of India is still in the stage of preliminary examination of the proposed acquisition of Ranbaxy Laboratories by Sun Pharmaceutical, which filed an application for clearance about two...To view the full article, register now.
Already a subscriber? Click here to view full article